{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Peptides and BPC 157: What's the deal?","description":"Peptides in Pain Management: BPC-157, Risks, Reality, and the Business of Regenerative Medicine Episode Length: ~12\u201315 minutes Target Audience: Pain physicians, anesthesiologists, PM&R, sports medicine, and regenerative medicine clinicians Hosted by: Dr. David Rosenblum, MD Produced by: PainExam | NRAP Academy \ud83e\udde0 Episode Overview Peptides like BPC-157 have exploded in popularity across regenerative medicine, sports medicine, and cash-based pain practices \u2014 but does the science support the hype? In this episode of PainExam, Dr. David Rosenblum takes a critical, evidence-based look at BPC-157 and other peptidesin pain management, examining: The biological rationale behind peptide therapy Preclinical and early human evidence for pain and tissue healing Regulatory status and safety concerns Ethical, legal, and marketing risks for physicians How peptides are currently being incorporated \u2014 and monetized \u2014 in pain practices This episode is designed to help clinicians separate science from marketing, and to approach peptide therapies with appropriate caution and professionalism. \u23f1\ufe0f Episode Breakdown \ud83d\udd39 00:00\u201301:30 \u2014 Introduction Why peptides are trending in pain and regenerative medicine What patients are asking \u2014 and what physicians need to know \ud83d\udd39 01:30\u201304:30 \u2014 What Is BPC-157? Origins of Body Protection Compound-157 Mechanisms: angiogenesis, inflammation modulation, tissue repair Summary of preclinical data and animal pain models \ud83d\udd39 04:30\u201307:00 \u2014 Evidence for Pain Relief & Healing Early inflammatory and non-inflammatory pain studies Intra-articular BPC-157 for knee pain: what the case series showed Why current human data are hypothesis-generating, not definitive \ud83d\udd39 07:00\u201309:30 \u2014 Risks, Unknowns & Regulatory Issues FDA status and investigational use Quality, purity, and dosing variability Theoretical biologic risks and drug interactions \ud83d\udd39 09:30\u201312:30 \u2014 The Business of Peptides in Pain Practice How peptides are marketed in regenerative clinics Cash-based models and patient demand Ethical marketing, informed consent, and medicolegal exposure \ud83d\udd39 12:30\u2013End \u2014 Clinical Takeaways Where peptides fit \u2014 and don\u2019t fit \u2014 in current pain practice Why evidence still matters in regenerative medicine \u26a0\ufe0f Key Clinical Takeaways BPC-157 shows promising preclinical data, but human evidence remains limited Current studies lack randomization, controls, and long-term outcomes Peptides are not FDA-approved for pain or musculoskeletal indications Marketing peptides without transparency poses ethical and legal risk Physicians must clearly distinguish experimental therapies from standard of care \ud83d\udcda Key References Discussed J\u00f3zwiak et al. Multifunctionality and Possible Medical Application of BPC-157 \u2014 MDPI Pharmaceuticals (2025) McGuire et al. Regeneration or Risk? A Narrative Review of BPC-157 \u2014 Current Reviews in Musculoskeletal Medicine (2025) Sikiri\u0107 et al. Effects of BPC-157 on Inflammatory and Non-Inflammatory Pain \u2014 Inflammopharmacology (1993) Lee & Padgett. Intra-Articular Injection of BPC-157 for Knee Pain \u2014 Alternative Therapies in Health and Medicine (2021) \ud83d\udce2 Sponsored Message \/ Advertisement \ud83d\udd14 Ready to Master Evidence-Based Pain Medicine? If you\u2019re preparing for Pain Medicine boards or looking to strengthen your foundation in interventional and regenerative pain management, check out the educational resources at: \ud83d\udc49 https:\/\/www.nrappain.org \ud83c\udf93 Offered through NRAP Academy: \u2705 PainExam\u00ae Pain Management Board Review \u2705 ABA, ABPM, FIPP, and ABIPP exam preparation \u2705 Ultrasound-guided pain procedure training \u2705 Regenerative pain medicine education \u2014 grounded in evidence, not hype \u2705 Virtual Pain Fellowship curriculum All content is designed by practicing pain physicians, for practicing pain physicians. \ud83c\udfaf Why Learn with NRAP Academy? Evidence-driven, board-relevant education Practical clinical insights you can apply immediately Trusted by physicians nationwide Focused on ethical, safe, and effective pain care \ud83d\udc49 Explore courses and upcoming programs at https:\/\/www.nrappain.org \ud83c\udfa7 Subscribe & Stay Sharp If you found this episode helpful: Subscribe to the PainExam Podcast Share it with a colleague Leave a review to help other pain physicians find evidence-based content Disclaimer: This podcast is for educational purposes only. Discussion of investigational therapies does not constitute endorsement or clinical recommendation. Physicians should follow applicable laws, regulations, and professional guidelines when considering experimental treatments.   References Lee, Edwin, and Blake Padgett. "Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain." Alternative Therapies in Health & Medicine 27.4 (2021). J\u00f3zwiak, Michalina, et al. "Multifunctionality and Possible Medical Application of the BPC 157 Peptide\u2014Literature and Patent Review." Pharmaceuticals 18.2 (2025): 185. McGuire, F. P., Martinez, R., Lenz, A., Skinner, L., & Cushman, D. M. (2025). Regeneration or risk? A narrative review of BPC-157 for musculoskeletal healing. Current Reviews in Musculoskeletal Medicine, 18(12), 611-619. ","author_name":"The PMRExam Podcast","author_url":"http:\/\/pmrexampodcast.libsyn.com\/podcast","html":"